PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018
In the FY12 period, SCMS will scope, plan and implement an effective pooled procurement and distribution mechanism for quality ARVs to be delivered to select PEPFAR Implementing Partners (IPs). Efficiency, availability, quality management and reduced stock obsolescence for ARVs will be the key program components. SCMS will assist the IPs in developing a pooled procurement model which enables ARVs to be efficiently procured and distributed while complying with the regulations and governance requirements of both PEPFAR and the GSA. The program will provide assistance in strengthening the IPs capacity and capability to develop efficient, sustainable long term healthcare supply chains which are sustainable. SCMS will leverage partnerships and private sector capacity, driving supply chain efficiencies, executing appropriate commodity consolidation and/or rapid response to distribution of ARVs.IP collaboration will be essential in developing this procurement and distribution approach, with clearly defined roles and responsibilities to establish the expected outcomes, timelines and deliverables for all the stakeholders.SCMS will receive $6,000,000 of the one-time VMMC funding for RSA to do a pooled procurement of disposable MMC kits. Kits will be distributed to USAID, DOD, and CDC IPs. This will optimize bulk discounts and simplify kit procurement and distribution. SCMS provides procurement, forecasting, distribution, inventory management, and quality assurance on the kits. While the VMMC target for one-time funding is 260,000, additive kits are required to accommodate training, errors, and potential exceeding of performance targets. It is estimated that at a price of $16.5 - $17 per kit, this procurement should render 352,000 363,000 single-use kits.
SCMS will receive $6,000,000 of the one-time VMMC funding for South Africa to do a pooled procurement of disposable MMC kits. Kits will be distributed to USAID, DOD, and CDC implementing partners. This will optimize bulk discounts and simplify kit procurement and distribution. SCMS provides procurement, forecasting, distribution, inventory management, and quality assurance on the kits. While the VMMC target for one-time funding is 260,000, additive kits are required to accommodate training, errors, and potential exceeding of performance targets. It is estimated that at a price of $16.5 - $17 per kit, this procurement should render 352,000 363,000 single-use kits.
The initial technical support phase will design the ARV supply chain management system in conjunction with the IPs and regulatory requirements. While the USG ARV Bridging Fund program experience will provide the foundation, there are some significant differences in the procurement and distribution under the IP program which will require consideration.
Key principles which require planning with the IPs include 1) implementing pooled procurement and distribution methods, to consolidate procurement orders and increasing volumes with which to negotiate lead times and freighting options to enable cost savings while supporting availability of ARVs, 2) developing well-planned quantification, procurement and distribution mechanisms to avert stock outs, overstocks, and emergency purchases through shared data, 3) developing an agreed IPs ARV list to pool procurement optimizing cost benefits, supporting harmonization with current guidelines, patient clinical requirements and the ultimate transition of patients to mainstream public sector service facilities.
SCMS will provide technical assistance support, determine and obtain necessary regulation/governance approvals, completing an analysis with IPs to determine supply chain requirements, collating an approved or tentatively approved FDA and MCC list of ARVs, identifying the options to obtain SEP exemption, agreeing a pooled procurement consolidated distribution model to plan warehousing and ordering procedures, determining quality assurance procedures and establishing M&E systems.
Once the technical approach is agreed, the SCMS operational support team will manage the forecasting, procurement, logistical requirements and provide M&E tracking for the selected ARVs from the regulated manufacturers to the IP healthcare facility sites. Aside from building supply chain management efficiencies for the ARVs shared SCMS expertise and knowledge across the partnerships will support the development of supply chain best practices for IPs to implement across their practices.
